Grace Montepiedra

Plasma biomarker factors associated with neurodevelopmental outcomes in children with perinatal HIV infection and controlled viremia.

Kapetanovic S, Giganti MJ, Abzug MJ, Lindsey JC, Sirois PA, Montepiedra G, Canniff J, Agwu A, Boivin MJ, Weinberg A.

AIDS. 2021 07 15. 35(9):1375-1384. PMID: 33710019

Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With Human Immunodeficiency Virus.

Theron G, Montepiedra G, Aaron L, McCarthy K, Chakhtoura N, Jean-Philippe P, Zimmer B, Loftis AJ, Chipato T, Nematadzira T, Nyati M, Onyango-Makumbi C, Masheto G, Ngocho J, Tongprasert F, Patil S, Lespinasse D, Weinberg A, Gupta A.

Clin Infect Dis. 2021 06 01. 72(11):e784-e790. PMID: 32997744

Viral hepatitis B and C in HIV-exposed South African infants.

Tamandjou Tchuem C, Cotton MF, Nel E, Tedder R, Preiser W, Violari A, Bobat R, Hovind L, Aaron L, Montepiedra G, Mitchell C, Andersson MI.

BMC Pediatr. 2020 12 24. 20(1):563. PMID: 33357228

Using a composite maternal-infant outcome measure in tuberculosis prevention studies among pregnant women.

Montepiedra G, Kim S, Weinberg A, Theron G, Sterling TR, LaCourse SM, Bradford S, Chakhtoura N, Jean-Philippe P, Evans S, Gupta A.

Clin Infect Dis. 2020 Nov 04. PMID: 33146706

A framework for considering the risk-benefit trade-off in designing noninferiority trials using composite outcome approaches.

Montepiedra G, Ramchandani R, Miyahara S, Kim S.

Stat Med. 2021 01 30. 40(2):327-348. PMID: 33105524

Pharmacokinetics and Drug-Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping.

Gausi K, Wiesner L, Norman J, Wallis CL, Onyango-Makumbi C, Chipato T, Haas DW, Browning R, Chakhtoura N, Montepiedra G, Aaron L, McCarthy K, Bradford S, Vhembo T, Stranix-Chibanda L, Masheto GR, Violari A, Mmbaga BT, Aurpibul L, Bhosale R, Nevrekhar N, Rouzier V, Kabugho E, Mutambanengwe M, Chanaiwa V, Nyati M, Mhembere T, Tongprasert F, Hesseling A, Shin K, Zimmer B, Costello D, Jean-Philippe P, Sterling TR, Theron G, Weinberg A, Gupta A, Denti P.

Clin Pharmacol Ther. 2021 Apr. 109(4):1034-1044. PMID: 32909316

Effects of Pregnancy and Isoniazid Preventive Therapy on M. tuberculosis Interferon Gamma Response Assays in Women with HIV.

Weinberg A, Aaron L, Montepiedra G, Sterling TR, Browning R, Mmbaga B, Vhembo T, Naik S, Kabugho E, Masheto G, Pahwa S, Mathad JS, LaCourse SM, McCarthy K, Bradford S, Theron G, Costello D, Zimmer B, Pierre MF, Gausi K, Denti P, Haas DW, Gupta A.

Clin Infect Dis. 2020 Jul 28. PMID: 32720695

HIV, Pregnancy, and Isoniazid Preventive Therapy. Reply.

Gupta A, Montepiedra G, Theron G.

N Engl J Med. 2020 03 19. 382(12):1184-1185. PMID: 32187483

Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials.

Miyahara S, Ramchandani R, Kim S, Evans SR, Gupta A, Swindells S, Chaisson RE, Montepiedra G.

Clin Infect Dis. 2020 02 03. 70(4):698-703. PMID: 31414121

Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women.

Gupta A, Montepiedra G, Aaron L, Theron G, McCarthy K, Bradford S, Chipato T, Vhembo T, Stranix-Chibanda L, Onyango-Makumbi C, Masheto GR, Violari A, Mmbaga BT, Aurpibul L, Bhosale R, Mave V, Rouzier V, Hesseling A, Shin K, Zimmer B, Costello D, Sterling TR, Chakhtoura N, Jean-Philippe P, Weinberg A.

N Engl J Med. 2019 10 03. 381(14):1333-1346. PMID: 31577875